MARKET

ACON

ACON

Aclarion Inc
NASDAQ
2.730
-0.030
-1.09%
After Hours: 2.690 -0.04 -1.47% 19:30 02/10 EST
OPEN
2.790
PREV CLOSE
2.760
HIGH
2.850
LOW
2.730
VOLUME
28.83K
TURNOVER
--
52 WEEK HIGH
229.50
52 WEEK LOW
2.340
MARKET CAP
7.79M
P/E (TTM)
-0.0016
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACON last week (0202-0206)?
Weekly Report · 1d ago
ACLARION INC - HAS CASH RUNWAY INTO 2028
Reuters · 5d ago
Aclarion Publishes 2026 Shareholder Letter from the Chairman
Barchart · 6d ago
Aclarion Expands Nociscan Availability In Los Angeles, Partners With Source Healthcare To Support Growth And Real-World Evidence Generation
Benzinga · 02/03 11:11
Aclarion Signs Agreement with Source Healthcare to Expand Nociscan Availability
Reuters · 02/03 11:00
Aclarion schließt Vereinbarung mit Source Healthcare zur Nutzung von Nociscan
Reuters · 02/03 11:00
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
Barchart · 02/03 05:00
Weekly Report: what happened at ACON last week (0126-0130)?
Weekly Report · 02/02 10:00
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.